Innate Immune Receptor NLRX1: Potential Modulator of Glioblastoma PathophysiologyDurgesh Meena, Sushmita Jha, Divya Shivakumar et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 4
Innate Immune Receptor NLRX1: Potential Modulator of Glioblastoma PathophysiologyDurgesh Meena, Sushmita Jha, Sushmita Rajkhowa et al.|Journal of Cellular Physiology|2026Cited by 2
Repurposing Nelfinavir: AIM2 Inflammasome-Driven Anti-tumor Effects in GlioblastomaDurgesh Meena, Sushmita Jha, Shalini Chhipa et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1
Cover Image, Volume 241, Number 5, May 2026Durgesh Meena, Sushmita Jha, Divya Shivakumar et al.|Journal of Cellular Physiology|2026Cited by 0
Unraveling the role of NLRP1-mediated inflammation in glioblastoma pathophysiology.Shalini Chhipa, Sushmita Jha, M.S. Revanth et al.|Journal of Clinical Oncology|2026Cited by 0